FDA Adverse Event Injury Summary report: N

INPEN MMT-105NNGYNA NOVO NORDISK GRAY

MDR report key: 11925325 · Received June 2, 2021

Report

Report Number
3012822846-2021-00492
Event Type
Injury
Date Received
June 2, 2021
Date of Event
November 15, 2020
Report Date
June 2, 2021
Manufacturer
COMPANION MEDICAL INC
Product Code
FMF
UDI-DI
000010862088000351
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THIS MDR IS RELATED TO THE RETROSPECTIVE REVIEW OF COMPLAINTS FROM COMPANION MEDICAL INC, FOLLOWING MEDTRONIC¿S ACQUISITION OF THE COMPANY IN SEPTEMBER 2020.

Description of Event or Problem · 1

THE CUSTOMER REPORTED VIA PHONE CALL THAT THERE WERE MULTIPLE INACCURACIES BETWEEN THE DOSES INTENDED AND DOSES RECORDED. THE DOSES WERE GREATER THAN 1.0 UNIT OF INSULIN. THE CUSTOMER REPORTED THEY EXPERIENCED HIGH BLOOD GLUCOSE. THE BLOOD GLUCOSE READING WAS 440 MG/DL. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PEN WILL NOT BE RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
821336 INPEN MMT-105NNGYNA NOVO NORDISK GRAY SYRINGE, PISTON FMF COMPANION MEDICAL INC MMT-105NNGYNA B92LN 000010862088000351

Patients

Seq Age Sex Outcome Treatment
1